Related Experiment Videos
RACK1 regulates G1/S progression by suppressing Src kinase activity.
Vidya Mamidipudi1, Jian Zhang, Kelly C Lee
1Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5187, USA.
Molecular and Cellular Biology
|July 16, 2004
Summary
RACK1 protein inhibits cancer cell growth by controlling the G(1) cell cycle checkpoint. It suppresses Src kinase activity, delaying DNA replication and cell division, revealing a new cancer control mechanism.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Cancer genes often target the G(1) cell cycle checkpoint, allowing uncontrolled cell division.
- RACK1 (Receptor for Activated C Kinase 1) was previously shown to inhibit Src tyrosine kinase and NIH 3T3 cell growth.
- RACK1 prolongs the G(0)/G(1) phase, suggesting a role in cell cycle regulation.
Purpose of the Study:
- To investigate the mechanism by which RACK1 influences the G(1) cell cycle checkpoint.
- To determine RACK1's role in regulating Src kinase activity and downstream signaling pathways.
- To elucidate RACK1's function in controlling cell proliferation in the context of cancer.
Main Methods:
- Overexpression of RACK1 in NIH 3T3 cells.
- Downregulation of RACK1 using short interference RNA (siRNA).
- Analysis of cell cycle progression (G(1) arrest, G(1)/S progression).
- Assessment of key cell cycle regulators (cyclins, CDKs, CDK inhibitors, transcription factors).
- Investigation of signaling pathways involving Src, Vav2, Rho GTPases, Stat3, and Myc.
Main Results:
- RACK1 overexpression induces a partial G(1) arrest by suppressing Src activity at the G(1) checkpoint.
- RACK1 inhibits downstream targets including Vav2, Rho GTPases, Stat3, and Myc via Src.
- Suppression of cyclin D1, CDK4, and CDK2; activation of p27 and retinoblastoma protein; sequestration of E2F1, leading to delayed G(1)/S progression.
- RACK1 downregulation activates Src-mediated signaling, accelerating G(1)/S progression.
- Stat3 is required for Rac1-induced Myc expression.
Conclusions:
- RACK1 acts as an endogenous inhibitor of Src kinase, providing novel cell cycle control at the late G(1) checkpoint.
- RACK1's mechanism involves suppressing Src activity, which subsequently inhibits key proteins driving cell cycle progression.
- This study reveals a new pathway for regulating cell division, with potential implications for cancer therapy targeting the G(1) checkpoint.